You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HLH

Showing 26 - 50 of 168
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chidamide, Hemophagocytic Lymphohistiocytosis Trial in Beijing (Chidamide combines with VP-16 and methylprednisolone)

Recruiting
  • Chidamide
  • Hemophagocytic Lymphohistiocytosis
  • Chidamide combines with VP-16 and methylprednisolone
  • Beijing, Beijing, China
    Beijing Friendship Hospital
Nov 29, 2021

Macrophage Activation Syndrome, Lymphohistiocytosis, Hemophagocytic, Arthritis, Juvenile Trial in Worldwide (Emapalumab)

Completed
Has Results
  • Macrophage Activation Syndrome
  • +3 more
  • Cincinnati, Ohio
  • +4 more
May 16, 2022

EBV Infection Trial in Beijing (PD1 antibody, lenalidomide)

Recruiting
  • EBV Infection
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Jan 4, 2022

PD-1, EBV Infection, Transplant Trial in Beijing (toripalimab injection)

Not yet recruiting
  • PD-1
  • +2 more
  • toripalimab injection
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Jun 27, 2021

AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

Recruiting
  • AML
  • +8 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 13, 2022

Squamous Cell Carcinoma of Head and Neck, Cancer, Carotid Stenosis Trial in Brussels (68GaNOTA-Anti-MMR-VHH2)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +7 more
  • Brussels, Brussel, Belgium
    Uz Brussel
Sep 2, 2022

Hemophagocytic Lymphohistiocytosis (HLH) Trial in Paris (Alemtuzumab, Methyl Prednisolone (MP), Cyclosporin A (CSA))

Completed
  • Hemophagocytic Lymphohistiocytosis (HLH)
  • Paris, France
    Hôpital Necker-Enfants Malades
Apr 13, 2021

HLH - Hypoplastic Left Heart Syndrome, DORV, DILV - Double Inlet Left Ventricle Trial in Columbus (Tissue Engineered Vascular

Recruiting
  • HLH - Hypoplastic Left Heart Syndrome
  • +10 more
  • Tissue Engineered Vascular Grafts
  • Columbus, Ohio
    Nationwide Children's Hospital
Aug 4, 2022

EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

Recruiting
  • EBV-associated Hemophagocytic Lymphohistiocytosis
  • EBV Infection
  • EBV-TCR-T cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Nov 12, 2023

Hemophagocytic Lymphohistiocytosis Trial in United States (Ruxolitinib, Dexamethasone, Etoposide)

Recruiting
  • Hemophagocytic Lymphohistiocytosis
  • Phoenix, Arizona
  • +9 more
Jan 9, 2023

Lymphoma-associated Hemophagocytic Lymphohistiocytosis

Recruiting
  • Lymphoma
  • Hemophagocytic Lymphohistiocytoses
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jun 1, 2023

    Interferon Gamma and Other Inflammatory Mediators in

    Completed
    • Hemophagocytic Lymphohistiocytosis
    • Blood Draws
    • Data Collection
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Mar 16, 2020

    Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection, Chronic Granulomatous Disease Trial in Canada,

    Completed
    Has Results
    • Hemophagocytic Lymphohistiocytosis
    • +5 more
    • Hematopoietic Stem Cell Transplant
    • Birmingham, Alabama
    • +21 more
    Dec 6, 2022

    COVID-19 Prospective Cohort for Identification of Secondary HLH

    Unknown status
    • COVID
      • München, Bavaria, Germany
        Department of nephrology, Klinikum rechts der Isar
      Apr 11, 2020

      Hemophagocytic Lymphohistiocytoses, Cytokine Storm Trial in Hangzhou (Dexamethasone, Etoposide, Ruxolitinib)

      Not yet recruiting
      • Hemophagocytic Lymphohistiocytoses
      • Cytokine Storm
      • Hangzhou, Zhejiang, China
        The Children's Hospital of Zhejiang University School of Medicin
      Aug 4, 2022

      Hemophagocytic Lymphohistiocytosis Trial in Canada, United States (ATG, rabbit, Etoposide, Methotrexate)

      Completed
      Has Results
      • Hemophagocytic Lymphohistiocytosis
      • ATG, rabbit
      • +4 more
      • Phoenix, Arizona
      • +14 more
      Sep 21, 2020

      Children and Adult Hemophagocytic Syndrome (HLHa)

      Completed
      • Hemophagocytic Syndrome
      • Identification of biological markers
      • Paris, France
        Clinical Research Unit
      Nov 19, 2021

      Adult Hemophagocytic Lymphohistiocytosis in Critically Ill

      Recruiting
      • Hemophagocytic Lymphohistiocytosis
        • Berlin, Germany
          Department of Anesthesiology and Operative Intensive Care Medici
        Jul 13, 2021

        Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (PID LPD), EBV+

        Recruiting
        • Epstein-Barr Virus (EBV)-Associated Diseases
        • +13 more
        • Tabelecleucel
        • Los Angeles, California
        • +39 more
        Nov 9, 2022

        Secondary Hemophagocytic Lymphohistiocytosis (sHLH) Trial in Worldwide (ELA026)

        Recruiting
        • Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
        • Innsbruck, Austria
        • +9 more
        Oct 24, 2022

        Primary Hemophagocytic Lymphohistiocytosis Trial in Worldwide (Emapalumab)

        Active, not recruiting
        • Primary Hemophagocytic Lymphohistiocytosis
        • Phoenix, Arizona
        • +27 more
        Nov 4, 2021

        COVID-19 Trial in Boston (Etoposide)

        Terminated
        • COVID-19
        • Boston, Massachusetts
          Boston Medical Center
        Jul 1, 2022

        Toxicities in Children and Adults With Cancer

        Active, not recruiting
        • Macrophage Activation Syndrome
        • Primary Hemophagocytic Lymphohistiocytosis
          • Bethesda, Maryland
            National Cancer Institute (NCI)
          Sep 17, 2022

          Leukemia Trial in Houston (Alemtuzumab, Etoposide, Dexamethasone)

          Active, not recruiting
          • Leukemia
          • Houston, Texas
            University of Texas MD Anderson Cancer Center
          Feb 2, 2022

          COVID-19 Trial in Philadelphia (Cyclosporine)

          Completed
          • COVID-19
          • Philadelphia, Pennsylvania
            University of Pennsylvania
          Jan 7, 2022